These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7921763)

  • 1. Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate.
    Chandran G; Ahern MJ; Hall PD; Geddes R; Smith MD; Hill W; Harley JH
    Br J Rheumatol; 1994 Oct; 33(10):981-4. PubMed ID: 7921763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
    Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
    Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis.
    Walker AM; Funch D; Dreyer NA; Tolman KG; Kremer JM; Alarcón GS; Lee RG; Weinblatt ME
    Arthritis Rheum; 1993 Mar; 36(3):329-35. PubMed ID: 8452577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cirrhosis due to methotrexate in a patient with rheumatoid arthritis.
    ter Borg EJ; Seldenrijk CA; Timmer R
    Neth J Med; 1996 Dec; 49(6):244-6. PubMed ID: 8990864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
    Willkens RF; Leonard PA; Clegg DO; Tolman KG; Ward JR; Marks CR; Greene ML; Roth GJ; Jackson CG; Cannon GW
    Ann Rheum Dis; 1990 Aug; 49(8):591-3. PubMed ID: 2396863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
    Tang KT; Hung WT; Chen YH; Lin CH; Chen DY
    Sci Rep; 2016 Mar; 6():22387. PubMed ID: 26928373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.
    Clegg DO; Furst DE; Tolman KG; Pogue R
    J Rheumatol; 1989 Aug; 16(8):1123-6. PubMed ID: 2585411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C.
    Tang KT; Chen YH; Lin CH; Chen DY
    Sci Rep; 2016 Sep; 6():33104. PubMed ID: 27609026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J; Petrelli M
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.
    Bergquist SR; Felson DT; Prashker MJ; Freedberg KA
    Arthritis Rheum; 1995 Mar; 38(3):326-33. PubMed ID: 7880186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
    Kremer JM; Lee RG; Tolman KG
    Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
    Kujala GA; Shamma'a JM; Chang WL; Brick JE
    Arthritis Rheum; 1990 Jul; 33(7):1037-41. PubMed ID: 2369419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
    Dubey L; Chatterjee S; Ghosh A
    Indian J Pharmacol; 2016; 48(5):591-594. PubMed ID: 27721549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis.
    Asai S; Nagai K; Takahashi N; Watanabe T; Matsumoto T; Asai N; Sobue Y; Ishiguro N; Kojima T
    Int J Rheum Dis; 2019 Feb; 22(2):207-213. PubMed ID: 30168274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.
    Kent PD; Luthra HS; Michet C
    J Rheumatol; 2004 Sep; 31(9):1727-31. PubMed ID: 15338491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.